Literature DB >> 18519576

An electroacoustic analysis of over-the-counter hearing aids.

Susanna Løve Callaway1, Jerry L Punch.   

Abstract

PURPOSE: To determine whether 11 over-the-counter (OTC) hearing devices have the flexibility to provide adequate gain and output for 3 common hearing loss configurations.
METHOD: The 11 OTC hearing devices were separated into 2 price groups: a low-range group (<$100) consisting of 8 hearing devices and a midrange group ($100-$500) consisting of 3 hearing devices. Gain and output were prescribed for 3 hearing loss configurations using National Acoustic Laboratories prescriptive procedures. Low-range hearing devices were measured electroacoustically, and technical specifications were used as the source of electroacoustic information for the midrange hearing devices.
RESULTS: Overall, midrange hearing devices met gain and output targets to a greater extent than did low-range devices. All low-range devices could be classified as special-purpose hearing aids with low-frequency emphasis. The low-range group had high equivalent input noise levels and potentially posed a residual hearing safety hazard.
CONCLUSIONS: The low-range OTC devices were found to be electroacoustically inadequate to meet the needs of the hearing impaired. Midrange OTC hearing devices are arguably a good solution for the cost-conscious consumer who cannot afford professional audiologic rehabilitation, especially if considered an interim step in the rehabilitation process.

Entities:  

Mesh:

Year:  2008        PMID: 18519576     DOI: 10.1044/1059-0889(2008/003)

Source DB:  PubMed          Journal:  Am J Audiol        ISSN: 1059-0889            Impact factor:   1.493


  15 in total

1.  A self-fitting hearing aid: need and concept.

Authors:  Elizabeth Convery; Gitte Keidser; Harvey Dillon; Lisa Hartley
Journal:  Trends Amplif       Date:  2011-12-04

Review 2.  Argumentum ad Ignorantiam: Smartphone-Connected Listening Devices.

Authors:  David W Maidment; Amyn M Amlani
Journal:  Semin Hear       Date:  2020-12-16

3.  Pilot Electroacoustic Analyses of a Sample of Direct-to-Consumer Amplification Products.

Authors:  Nicholas S Reed; Joshua Betz; Frank R Lin; Sara K Mamo
Journal:  Otol Neurotol       Date:  2017-07       Impact factor: 2.311

Review 4.  Disruptive Hearing Technologies and Mild Sensorineural Hearing Loss II: Current Research on Affordable Hearing Technologies and Direct-to-Consumer Models.

Authors:  Anna Marie Jilla; Carole E Johnson; Jeffrey L Danhauer
Journal:  Semin Hear       Date:  2018-06-15

Review 5.  Personal Sound Amplifiers for Adults with Hearing Loss.

Authors:  Sara K Mamo; Nicholas S Reed; Carrie L Nieman; Esther S Oh; Frank R Lin
Journal:  Am J Med       Date:  2015-10-21       Impact factor: 4.965

6.  Electroacoustic Evaluation of Smartphone-Based Hearing Aid Applications.

Authors:  Willy Nguyen; Miseung Koo; Jun Ho Lee; Seung-Ha Oh; Moo Kyun Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2022-02-08       Impact factor: 3.340

7.  Clinical evaluation of an over-the-counter hearing aid (TEO First®) in elderly patients suffering of mild to moderate hearing loss.

Authors:  Guillaume Sacco; Sébastien Gonfrier; Bernard Teboul; Ivan Gahide; Fredéric Prate; Mathilde Demory-Zory; Jean-Michel Turpin; Claire Vuagnoux; Philippe Genovese; Stéphane Schneider; Olivier Guérin; Nicolas Guevara
Journal:  BMC Geriatr       Date:  2016-07-09       Impact factor: 3.921

Review 8.  Applications of direct-to-consumer hearing devices for adults with hearing loss: a review.

Authors:  Vinaya Manchaiah; Brian Taylor; Ashley L Dockens; Nicole R Tran; Kayla Lane; Mariana Castle; Vibhu Grover
Journal:  Clin Interv Aging       Date:  2017-05-18       Impact factor: 4.458

9.  Outcomes of Direct-to-Consumer Hearing Devices for People with Hearing Loss: A Review.

Authors:  Nicole R Tran; Vinaya Manchaiah
Journal:  J Audiol Otol       Date:  2018-08-22

10.  Over-the-Counter Hearing Aids: A Lost Decade for Change.

Authors:  Zoe Yee Ting Chan; Bradley McPherson
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.